heart iconheart icon
Share
Our Company
Johnson & Johnson Adds Hospital Medical Devices to Sandra Peterson Responsibilities

NEW BRUNSWICK, N.J., Feb. 2, 2017 – Johnson & Johnson (NYSE: JNJ) today announced that in addition to her current responsibilities, Sandra Peterson, Group Worldwide Chair, will assume leadership of its Hospital Medical Device business, effective June 1, when Gary Pruden, Worldwide Chair, Medical Devices, retires.

In addition to the Hospital Medical Device business, Peterson will continue to oversee a broad portfolio of businesses, functions and capabilities including: the Consumer and Consumer Medical Device businesses, Supply Chain, Information Technology, Global Services, Health & Wellness, Global Design and Health Technology.

“Since joining the company more than four years ago, Sandi has been a valuable partner and has played a critical role in positioning Johnson & Johnson to thrive in a rapidly changing environment,” said Alex Gorsky, Chairman and Chief Executive Officer. “Under Sandi’s leadership, our Consumer and Consumer Medical Device businesses have improved significantly, and the quality and efficiency of our operating infrastructure have been notably strengthened. Sandi has a proven track record and brings broad-based experience and a strategic, global perspective to our Hospital Medical Device business.”

Sandi has had an extensive global career in health care, life sciences, consumer goods, and consulting. Most recently, she was Chairman & CEO of Bayer CropScience AG in Germany. Previously, she was CEO of Bayer Medical Care. While at Bayer, Sandi also served as a member of the Board of Directors of AdvaMed, the Advanced Medical Technology Association. Sandi is a member of the Board of Directors of Microsoft, and a member of the Board of Trustees of the Institute of Advanced Study.

About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,900 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

  • Press Contacts:
    Ernie Knewitz
    (732) 524-6623
    (917) 697-2318 (M)

    Investor Contacts:
    Joseph Wolk
    Jwolk2@its.jnj.com
    (732) 524-1142